Baxter International Inc. BAX
23.37
(0.11)
(0.47%)
as of 25 Sep
- Market cap
- $12.2B
- P/E
- 0.0×
Follow BAX
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Baxter International Inc. (BAX) Debt to equity
Baxter International Inc.'s debt to equity at the end of the quarter to 30 June 2026 was 1.5×, down 0.0× from fiscal 2025 (1.6×). Over the past ten years it has ranged from 0.3× (fiscal 2016) to 2.8× (fiscal 2022); the current reading is higher than 64% of that period. That is above the Medical Instruments & Supplies industry median of 0.1× and above the Healthcare sector median of 0.0×.
Debt to equity, annual
Annual
| Period | Debt to equity | Change |
|---|---|---|
| FY2025 | 1.6× | (16.90%) |
| FY2024 | 1.9× | 15.03% |
| FY2023 | 1.6× | (42.44%) |
| FY2022 | 2.8× | 45.75% |
| FY2021 | 1.9× | 172.86% |
| FY2020 | 0.7× | 4.94% |
| FY2019 | 0.7× | 52.64% |
| FY2018 | 0.4× | 14.98% |
| FY2017 | 0.4× | 14.67% |
| FY2016 | 0.3× | (54.22%) |
Quarterly
| Period | Debt to equity | Change |
|---|---|---|
| Jun 2026 | 1.5× | (2.68%) |
| Mar 2026 | 1.6× | 1.29% |
| Dec 2025 | 1.6× | 17.89% |
| Sep 2025 | 1.3× | 1.12% |
| 42 more quarters | Free account |
Against its own ten years
Low 0.3×
High 2.8×
Ten-year median
0.7×
Current reading's percentile
64
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| ALGN Align Technology, Inc. compare | 0.0× |
| RGEN Repligen Corporation compare | 0.3× |
| STVN Stevanato Group S.p.A. compare | 0.3× |
| COO The Cooper Companies, Inc. compare | 0.3× |
| ATR AptarGroup, Inc. compare | 0.5× |
| AVTR Avantor, Inc. compare | 0.7× |
| BLCO Bausch + Lomb Corporation compare | 0.8× |
| SOLV Solventum Corporation compare | 1.1× |
| BAX Baxter International Inc. | 1.5× |
| Medical Instruments & Supplies industry median | 0.1× |
| Healthcare sector median | 0.0× |
| Market median | 0.2× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)
More on BAX
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement